| scholarly article | Q13442814 |
| P2093 | author name string | S Virudachalam | |
| R J Bold | |||
| B N Fahy | |||
| M Schlieman | |||
| P2860 | cites work | Quantitative prediction of NF-kappa B DNA-protein interactions | Q24298906 |
| NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis | Q24554454 | ||
| The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. | Q33783562 | ||
| Phosphoinositide 3-kinase signalling pathways | Q33940898 | ||
| 26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer | Q33950784 | ||
| Differential roles of Akt, Rac, and Ral in R-Ras-mediated cellular transformation, adhesion, and survival | Q33959533 | ||
| The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). | Q33962748 | ||
| Use of kinase inhibitors to dissect signaling pathways. | Q33979180 | ||
| Ten years of protein kinase B signalling: a hard Akt to follow | Q34432885 | ||
| Present and future treatment of pancreatic cancer | Q34718249 | ||
| Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status | Q36691968 | ||
| The akt kinase: molecular determinants of oncogenicity | Q36758478 | ||
| Prognostic factors in resectable pancreatic cancer: p53 and bcl-2. | Q38467361 | ||
| Bcl-x(L) antisense oligonucleotides induce apoptosis and increase sensitivity of pancreatic cancer cells to gemcitabine | Q40680294 | ||
| NF-kappaB inhibition enhances peroxynitrite-induced enterocyte apoptosis | Q40717021 | ||
| NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells | Q40729431 | ||
| Transforming growth factor-beta 2 is a transcriptional target for Akt/protein kinase B via forkhead transcription factor | Q40732071 | ||
| Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer | Q40769199 | ||
| Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane | Q40816351 | ||
| Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. | Q40831748 | ||
| Rel/NF-kappaB represses bcl-2 transcription in pro-B lymphocytes. | Q40882464 | ||
| Phosphatidylinositol 3'-kinase, but not S6-kinase, is required for insulin-like growth factor-I and IL-4 to maintain expression of Bcl-2 and promote survival of myeloid progenitors. | Q40960813 | ||
| Identification of a p53-dependent negative response element in the bcl-2 gene | Q41461046 | ||
| Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin | Q42503199 | ||
| Role of Akt in growth and survival of PANC-1 pancreatic cancer cells | Q43821002 | ||
| Inhibition of the phosphatidylinositol 3'-kinase-AKT pathway induces apoptosis in pancreatic carcinoma cells in vitro and in vivo | Q44248593 | ||
| Gemcitabine-induced programmed cell death (apoptosis) of human pancreatic carcinoma is determined by Bcl-2 content | Q45858399 | ||
| The Ras/phosphatidylinositol 3-kinase and Ras/ERK pathways function as independent survival modules each of which inhibits a distinct apoptotic signaling pathway in sympathetic neurons | Q48563846 | ||
| Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells. | Q54033430 | ||
| A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells | Q64379556 | ||
| Activation of Akt kinase inhibits apoptosis and changes in Bcl-2 and Bax expression induced by nitric oxide in primary hippocampal neurons | Q64381195 | ||
| Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN | Q64381461 | ||
| Expression of Bcl-2 and p53 protein in resectable invasive ductal carcinoma of the pancreas: effects on clinical outcome and efficacy of adjuvant chemotherapy | Q73688006 | ||
| Pancreatic cancer cell proliferation is phosphatidylinositol 3-kinase dependent | Q73712391 | ||
| Mcl-1 is a common target of stem cell factor and interleukin-5 for apoptosis prevention activity via MEK/MAPK and PI-3K/Akt pathways | Q74232608 | ||
| The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells | Q77904111 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreatic cancer | Q212961 |
| cancer cell line | Q23058136 | ||
| P304 | page(s) | 391-397 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2 | |
| P478 | volume | 89 |
| Q28486199 | Anti-pancreatic cancer deliverables from sea: first-hand evidence on the efficacy, molecular targets and mode of action for multifarious polyphenols from five different brown-algae |
| Q36835642 | Apoptotic pathways in pancreatic ductal adenocarcinoma |
| Q35100914 | Citrobacter rodentium-induced NF-kappaB activation in hyperproliferating colonic epithelia: role of p65 (Ser536) phosphorylation |
| Q36182734 | Clusterin silencing sensitizes pancreatic cancer MIA-PaCa-2 cells to gmcitabine via regulation of NF-kB/Bcl-2 signaling |
| Q41270773 | Combination of celecoxib (Celebrex®) and CD19 CAR-redirected CTL immunotherapy for the treatment of B-cell non-Hodgkin's lymphomas |
| Q33792279 | Curcumin analogues exhibit enhanced growth suppressive activity in human pancreatic cancer cells |
| Q38946429 | Emerging Role and Targeting of Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) in Human Malignancies |
| Q35578720 | Enhanced antitumor efficacy of gemcitabine by evodiamine on pancreatic cancer via regulating PI3K/Akt pathway |
| Q39535549 | FKBP51 protects 661w cell culture from staurosporine-induced apoptosis. |
| Q28484635 | Gatifloxacin induces S and G2-phase cell cycle arrest in pancreatic cancer cells via p21/p27/p53 |
| Q34384695 | Grape proanthocyanidin inhibit pancreatic cancer cell growth in vitro and in vivo through induction of apoptosis and by targeting the PI3K/Akt pathway |
| Q38727311 | Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression. |
| Q34721443 | High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma |
| Q36648105 | Incidence, mechanism and prognostic value of activated AKT in pancreas cancer |
| Q35719620 | Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma |
| Q40457650 | Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions. |
| Q40206683 | Lentivirus-mediated RNA interference of HMGA1 promotes chemosensitivity to gemcitabine in pancreatic adenocarcinoma |
| Q40435304 | Modulation of tamoxifen sensitivity by antisense Bcl-2 and trastuzumab in breast carcinoma cells |
| Q35741836 | Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activation |
| Q34680322 | Nanoparticle delivery of an AKT/PDK1 inhibitor improves the therapeutic effect in pancreatic cancer. |
| Q38812160 | New Treatment of Medullary and Papillary Human Thyroid Cancer: Biological Effects of Hyaluronic Acid Hydrogel Loaded With Quercetin Alone or in Combination to an Inhibitor of Aurora Kinase. |
| Q53700817 | Overcoming chemoresistance in pancreatic cancer cells: role of the bitter taste receptor T2R10. |
| Q40181453 | PTEN down regulates AP-1 and targets c-fos in human glioma cells via PI3-kinase/Akt pathway |
| Q30499567 | Pancreatic tumor suppression by benzyl isothiocyanate is associated with inhibition of PI3K/AKT/FOXO pathway |
| Q58586943 | Potential Anti-Inflammatory and Anti-Cancer Properties of Farnesol |
| Q40213093 | Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB. |
| Q41682526 | RLN2 Is a Positive Regulator of AKT-2-Induced Gene Expression Required for Osteosarcoma Cells Invasion and Chemoresistance |
| Q37324457 | RNA interference demonstrates a novel role for integrin-linked kinase as a determinant of pancreatic adenocarcinoma cell gemcitabine chemoresistance |
| Q40615849 | RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity |
| Q45099758 | Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen |
| Q39025559 | Role of autophagy in apoptotic regulation by Akt in pancreatic cancer |
| Q35954519 | Sensitization of squamous cell carcinoma to cisplatin induced killing by natural agents |
| Q37030872 | Targeting synuclein-gamma to counteract drug resistance in cancer |
| Q40507359 | The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells |
| Q42991719 | The Role of Platelet-Derived ADP and ATP in Promoting Pancreatic Cancer Cell Survival and Gemcitabine Resistance |
| Q34494019 | The molecular targets for the diagnosis and treatment of pancreatic cancer |
| Q35983641 | The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation. |
| Q36020360 | The role of Akt activation in the response to chemotherapy in pancreatic cancer |
| Q36773130 | The role of chemoradiation for patients with resectable or potentially resectable pancreatic cancer |
| Q93046345 | Therapeutic Effect of pHLIP-mediated CEACAM6 Gene Silencing in Lung Adenocarcinoma |
| Q81285585 | [Pathogenesis of the ductal pancreatic adenocarcinoma: implications for future therapies?] |
| Q37448131 | miR-221 promotes growth and invasion of hepatocellular carcinoma cells by constitutive activation of NFκB. |
Search more.